Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cala Health
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cala Health

Cala Health

Series D

Cala Health: Pioneering bioelectronic medicine for transformative chronic disease care.

HQ
Burlingame, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Cala Health, founded with a mission to revolutionize chronic disease care through bioelectronic medicine, focuses on developing non-invasive therapies for conditions such as essential tremor. The company's flagship product, the Cala kIQ™ System, offers on-demand tremor relief through targeted electrical stimulation. Cala Health aims to transform the standard of care by providing patients with innovative, effective alternatives to traditional treatments.

Notable figures associated with Cala Health include its leadership team and a board of advisors comprising experts in neurology and medical device innovation. The company has garnered significant attention and investment from leading healthcare venture capital firms. Key achievements include the nomination of the Cala kIQ™ System for the 2024 Prix Galien International Award, underscoring its potential impact on patient care. Cala Health continues to make strides in bioelectronic medicine, improving the quality of life for individuals with chronic conditions.

Cala Health - Quick Facts

When was Cala Health founded?

Cala Health was founded in 2014.

Where is Cala Health's headquarters located?

Cala Health's headquarters is located in Burlingame, CA, US.

When was Cala Health's last funding round?

Cala Health's most recent funding round was for $77M (USD) in November 2021.

How much has Cala Health raised to-date?

As of Nov 16, 2021, Cala Health has raised a total of $148.3M (USD).

How many employees does Cala Health have?

Cala Health has 85 employees as of Feb 5, 2024.

Cala Health - Classification

Industry
  • Hardware
  • Therapeutics
Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
  • Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified